| Literature DB >> 21218112 |
Jana Buchancová1, Hubert Poláček, Henrieta Hudečková, Lukáš Murajda, Oto Osina, Jela Valachová.
Abstract
Electrolytic production of aluminium in former Czechoslovakia started in the year 1953 in the Žiar valley in the central Slovakia. However, till 1995 the hygienic conditions for health protection were not met in the factory. It underwent a reconstruction afterwards.The authors demonstrate cases of occupational skeletal fluorosis (currently rare in Europe) in 14 metallurgists which were all disclosed in foundry workers in Žiar nad Hronom as to the year 2005. The occupational disease was diagnosed after 17.7 ± 7.67 years (x±SD) of exposure in the foundry.The authors describe the clinical conditions, haematological and biochemical tests (decreased level of ionising calcium was found in serum). The content of fluorides in urine was increased (254.4±130.95 µmol/l). The average age of patients at the time of recognition of the professional etiology of the disease was 57.93±7.95 years. Eight patients were older than 60 years. Skeletal abnormalities were evaluated by using X-ray skiagraphy, estimating the Stage I-III of the skeletal fluorosis. Typically an increase of bone density was found, the compact part of long bones was coarsed, there were calcifications of the interosseous membrane between radius and ulna and some ossifications of the sacrospinal and sacrotuberous ligaments. Twelve patients suffered sensorimotor polyneuropathy of extremities, chronic bronchitis was found in 6 patients (two of them were smokers).The last occupational case was registered in the year 2001. The authors assume that aluminium production with modern technology of better safety and protection of health of workers is the key which will make the skeletal fluorosis the history in the Czech and Slovak Republic.Entities:
Keywords: fluorides in urine; health status; hypocalcaemia; x-ray evaluation of skeleton
Year: 2008 PMID: 21218112 PMCID: PMC2993488 DOI: 10.2478/v10102-010-0038-7
Source DB: PubMed Journal: Interdiscip Toxicol ISSN: 1337-6853
Selected laboratory findings (x ± SD) among the group of patients with the diagnosis of bone fluorosis.
| Parameter | Values | |||
|---|---|---|---|---|
| X ± SD | Min. | Max. | Normal Range | |
| Hemoglobin(g/l) | 138.59±26.75 | 84.00 | 161.00 | 130–160 |
| Glycaemia fasting(mmol/l) | 5.71±1.63 | 3.92 | 7.92 | 3.3–5.5 |
| Serum cholesterol(mmol/l) | 6.30±1.25 | 3.80 | 7.92 | 2.8–5.2 |
| Serum calcium(mmol/l) | 2.4±0.14 | 2.20 | 2.65 | 2.15–2.55 |
| Ionized serum calcium(mmol/l) | 1.07±0.07 | 0.95 | 1.14 | 2.15–2.55 |
| Serum phosphorus(mmol/l) | 0.94±0.16 | 0.71 | 1.16 | 0.87–1.45 |
| Alkaline phosphatase(kat/l) | 1.04±0.44 | 0.50 | 1.46 | 0.8–2.2 |
| Fluorides in urine(mol/l) | 254.54±130.95 | 32.00 | 491.10 | up to 50 |
(n=14)
Figure 1Skeletal fluorosis (Stage II–III). Osteosclerosis of diaphyses of forearm and calcification in membrana interossea (arrows).
Figure 3Skeletal fluorosis (Stage III). Exostoses in area of foramen obturatorium dx. I (low arrows).
Figure 2Skeletal fluorosis (Stage II). Tibiae and fibulae thinning, ill defined margines (arrows).
Figure 4Skeletal fluorosis (Stage III). Pseudoperiostoses of lower margines of ribs (arrows).